A. V. Kononenko

A. V. Kononenko

Auto-generated profile, based on publicly available information

A. V. Kononenko

National University of Pharmacy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Problems of Balneology, Physiotherapy and Exercise Therapy
Verified
Journal Article
Closed access
PDF file
NBN. D. Bunyatyan
N. D. Bunyatyan
SDS. M. Drogovoz
S. M. Drogovoz
AKA. V. Kononenko
A. V. Kononenko
APA. B. Prokofiev
A. B. Prokofiev
НБН. Д. Бунятян
Н. Д. Бунятян
Carboxytherapy (the treatment based on carbon dioxide injections) is a multipurpose and widely used medical technology. The use of CO2 injections (intracutaneous, subcutaneous, and pneumopuncture) have substantially supplemented and increased the practical relevance of carboxytherapy as a method for the treatment of many diseases. Thanks to it physiological properties, CO2 has antihypoxic, antioxidant, vasodilatory, anti-inflammatory, analgesic, and spasmolytic activities; moreover, it improves blood viscosity, stimulates neoangiogenesis, and regenerative processes. Carbon dioxide is a sort of biochemical 'peacemaker' in tissue oxygenation: when blood cells are exposed to high CO2 concentrations (Bohr effect), the rate of gas exchange (CO2 and O2) increases. The human organism interprets carboxytherapy (local hypercapnia) as oxygen deficiency and responses to it by boosting not only the blood flow, but also the vascular endothelial growth factor which stimulates neoangiogenesis and in the long run improves blood supply and tissue trophism. The multiple mechanisms of action, polymodal efficacy, a tool kit with a wide range of detectors and various modes of treatment make carboxytherapy a popular medical technology all over the world, namely in cosmetology, dermatology, aesthetic medicine, angiology, orthopaedics, cardiology, neurology, pulmonology, gynaecology, urology, proctology, plastic and general surgery, and other areas. Carboxytherapy provides a perfect example of the off-label usage in medicine that made it one of the most extensively applied medical technology for the treatment of various diseases despite the lack of the preclinical data and scarce relevant information available in textbooks, reference books and booklets.

21 September 2013 in Chemistry of Natural Compounds
Verified
Journal Article
Closed access
PDF file
EKE. V. Krivoruchko
E. V. Krivoruchko
OAO. A. Andrushchenko
O. A. Andrushchenko
AKA. V. Kononenko
A. V. Kononenko

1 August 2017 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
NBN. D. Bunyatyan
N. D. Bunyatyan
IBI. P. Bukhtiyarova
I. P. Bukhtiyarova
SDS. M. Drogovoz
S. M. Drogovoz
AKA. V. Kononenko
A. V. Kononenko
YOYu. V. Olefir
Yu. V. Olefir
DGD. V. Goryachev
D. V. Goryachev

1 January 2019 in Problems of Balneology, Physiotherapy and Exercise Therapy
Verified
Journal Article
Closed access
PDF file
NBN D Bunyatyan
N D Bunyatyan
SDS M Drogovoz
S M Drogovoz
ASA L Shtroblya
A L Shtroblya
AKA V Kononenko
A V Kononenko
HZHana Zelenkova
Hana Zelenkova
LNLudmila Nikolaeva
Ludmila Nikolaeva
The problem of finding new ways for pharmacological prophylaxis and treatment of respiratory tract diseases is very relevant in public health. To eliminate hypoxia, many European and American clinics use carboxytherapy as an additional or alternative treatment. Carbon dioxide administration eliminates the sequels of oxygen starvation, by producing artificial tissue hypercapnia, which causes an increase in oxygen delivery and carbon dioxide removal from the tissues and then from the body. The main mechanism of action of carboxytherapy is associated with enhanced tissue oxygenation and is due to the Verigo-Bohr effect: the effect of CO2 concentration and pH on the binding of hemoglobin to oxygen and release of the latter from hemoglobin. By affecting the chemoreceptors of the respiratory center, carboxytherapy contributes to increased pulmonary ventilation and reduces bronchial smooth muscle tone and bronchial mucous secretion, as well as inflammation; all this improves breathing. By exerting a direct and reflex effect on the respiratory center, carboxytherapy induces hurried and deeper breathing, which increases pulmonary ventilation, speeds up perfusion and gas exchange in the lung, eliminates dyspnea and bronchospasm; therefore, it is widely used for lung diseases (asthma, pneumosclerosis, and silicosis). Carboxytherapy improves lung function in case of bronchopulmonary diseases, performance, and quality of life and it is used as an additional method in the pharmacotherapy of many diseases in pulmonology.

1 October 2018 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
NBN. D. Bunyatyan
N. D. Bunyatyan
EKE. A. Kal’ko
E. A. Kal’ko
SDS. M. Drogovoz
S. M. Drogovoz
AKA. V. Kononenko
A. V. Kononenko

31 December 2023 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
ABAnastasiia Belikova
Anastasiia Belikova
LILiudas Ivanauskas
Liudas Ivanauskas
LSLyudmila Sidorenko
Lyudmila Sidorenko
VCVasyl Chorny
Vasyl Chorny
AKAnna Kononenko
Anna Kononenko
VGVictoriya A. Georgiyants
Victoriya A. Georgiyants
Pharmaceutical companies in Ukraine aspire to develop their innovative medicinal products and successfully introduce them to the global market. However, along with the prospects of increased usage of these pharmaceuticals, there arises a challenge of heightened waste production, making them a part of the over twenty million tons of PPCPs produced annually. Consequently, one of the tasks in producing new pharmaceuticals is the development of methodologies and approaches not only for quality control but also for their determination in the environment matrices. The aim. Develop and validate GC-FID chromatographic method for the simultaneous determination of Enisamium iodide and Tilorone dihydrochloride, evaluate their applicability, and compare their "greenness" with the previously developed HPLC method. Materials and methods. The determination of the Tilorone dihydrochloride and Enisamium iodide was carried out by gas chromatography with a flame ionization detector using the Rxi-5 ms (30 m long, 0.25 mm outer diameter and 0.25 μm liquid stationary phase thickness) Results. Chromatographic GC-FID methods have been developed for the simultaneous determination of Enisamium iodide and Tilorone dihydrochloride. Optimal sample preparation conditions were established, and a validation process was conducted. A comparison with the previously developed HPLC method was made regarding "greenness." Conclusions. The developed GC-FID methodology is accurate and more environmentally friendly compared to the previously established methods. It can be recommended to determine Enisamium iodide and Tilorone dihydrochloride in the environmental matrices. It is considered environmentally friendly based on the overall GREENness (AGREE) scale, scoring 0.73 (>0.70), which demonstrates the environmentally favourable nature of the proposed analytical approach